-
hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2011.pdf
January 01, 2011 - Variance estimates must take into account both the sampling
design and the form of the statistic. … stratification of
public versus private, with the voluntary and proprietary hospitals combined to form … The two samples could be combined to form a single,
generalizable 20% subsample of discharges.
-
www.ahrq.gov/sites/default/files/wysiwyg/npsd/data/npsd-chartbook-2019.pdf
January 01, 2019 - ■ In CFER-H V1.1 and V1.2, the REPORT TYPE is found in the Healthcare Event
Reporting Form (HERF) Data … 0.5% 1.0% 1.7%
• Technical Notes
■ In CFER-H V1.2, the EXTENT OF HARM in the Patient Information Form … • Technical Notes
■ In CFER-H V1.2, LOCATION is captured in the Summary of Initial Report form DE … Medication or substance known to be an
allergen to patient
Incorrect preparation
Incorrect dosage form … patient
Incorrect patient/family action
Incorrect route
Incorrect preparation
Incorrect dosage form
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2002_SummaryStats_SEVERITY.PDF
January 01, 2002 - .**
3940: OTH O.R PROC BLOOD&BLOOD FORM ORG W/O CC 860 0.01
3941: OTH O.R PROC BLOOD&BLOOD FORM ORG … W CC 619 0.01
3942: OTH O.R PROC BLOOD&BLOOD FORM ORG W MCC 183 0.00
3950: RED BLOOD CELL DISORDERS
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2004_SummaryStats_SEVERITY.PDF
January 01, 2004 - SPLENECTOMY AGE 0-17 W CC 71 0.00
3932: SPLENECTOMY AGE 0-17 W MCC 14 0.00
3940: OTH O.R PROC BLOOD&BLOOD FORM … ORG W/O CC 937 0.01
3941: OTH O.R PROC BLOOD&BLOOD FORM ORG W CC 726 0.01
3942: OTH O.R PROC BLOOD … &BLOOD FORM ORG W MCC 265 0.00
3950: RED BLOOD CELL DISORDERS AGE >17 W/O CC 19470 0.24
3951: RED BLOOD
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2003_SummaryStats_SEVERITY.PDF
January 01, 2003 - .**
3940: OTH O.R PROC BLOOD&BLOOD FORM ORG W/O CC 827 0.01
3941: OTH O.R PROC BLOOD&BLOOD FORM ORG … W CC 642 0.01
3942: OTH O.R PROC BLOOD&BLOOD FORM ORG W MCC 212 0.00
3950: RED BLOOD CELL DISORDERS
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2006_MaskedStats_Severity.PDF
January 01, 2006 - SPLENECTOMY AGE 0-17 W CC 58 0.00
3932: SPLENECTOMY AGE 0-17 W MCC 12 0.00
3940: OTH O.R PROC BLOOD&BLOOD FORM … ORG WO CC 891 0.01
3941: OTH O.R PROC BLOOD&BLOOD FORM ORG W CC 779 0.01
3942: OTH O.R PROC BLOOD& … BLOOD FORM ORG W MCC 323 0.00
3950: RED BLOOD CELL DISORDERS AGE >17 WO CC 18613 0.23
3951: RED BLOOD
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2005_SummaryStats_SEVERITY.PDF
January 01, 2005 - SPLENECTOMY AGE 0-17 W CC 70 0.00
3932: SPLENECTOMY AGE 0-17 W MCC 24 0.00
3940: OTH O.R PROC BLOOD&BLOOD FORM … ORG WO CC 965 0.01
3941: OTH O.R PROC BLOOD&BLOOD FORM ORG W CC 738 0.01
3942: OTH O.R PROC BLOOD& … BLOOD FORM ORG W MCC 283 0.00
3950: RED BLOOD CELL DISORDERS AGE >17 WO CC 18546 0.23
3951: RED BLOOD
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2003_SummaryStats_10PCT_SEVERITY_B.PDF
January 01, 2003 - .**
3940: OTH O.R PROC BLOOD&BLOOD FORM ORG W/O CC 81 0.01
3941: OTH O.R PROC BLOOD&BLOOD FORM ORG … W CC 69 0.01
3942: OTH O.R PROC BLOOD&BLOOD FORM ORG W MCC 25 0.00
3950: RED BLOOD CELL DISORDERS AGE
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/m_E9nFrmxuS5-surqVHK2u
November 13, 2018 - unhealthy alcohol use may prevent deleterious health
effects and help prevent progression to more severe forms … Conflict of Interest Disclosures: All authors have
completed and submitted the ICMJE Form for
Disclosure … AUDIT-3 and AUDIT-4: effectiveness of two short
forms of the Alcohol Use Disorders Identification
Test
-
digital.ahrq.gov/ahrq-funded-projects/privacy-and-security-solutions-interoperable-hie-or
January 01, 2023 - Privacy and Security Solutions for Interoperable Health Information Exchange / Oregon
Project Description
Project Details -
Completed
Contract Number
290-05-0015-RTI-007
Funding Mechanism(s)
Health Information Security and Privacy Colla…
-
digital.ahrq.gov/ahrq-funded-projects/privacy-and-security-solutions-interoperable-hie-nm
January 01, 2023 - Privacy and Security Solutions for Interoperable Health Information Exchange / New Mexico
Project Description
Project Details -
Completed
Contract Number
290-05-0015-RTI-013
Funding Mechanism(s)
Health Information Security and Privacy C…
-
digital.ahrq.gov/ahrq-funded-projects/privacy-and-security-solutions-interoperable-hie-ut
January 01, 2023 - Privacy and Security Solutions for Interoperable Health Information Exchange / Utah
Project Description
Project Details -
Completed
Contract Number
290-05-0015-RTI-014
Funding Mechanism(s)
Health Information Security and Privacy Collabo…
-
digital.ahrq.gov/ahrq-funded-projects/privacy-and-security-solutions-interoperable-hie-co
January 01, 2023 - Privacy and Security Solutions for Interoperable Health Information Exchange / Colorado
Project Description
Project Details -
Completed
Contract Number
290-05-0015-RTI-033
Funding Mechanism(s)
Health Information Security and Privacy Col…
-
digital.ahrq.gov/ahrq-funded-projects/privacy-and-security-solutions-interoperable-hie-ak
January 01, 2023 - Privacy and Security Solutions for Interoperable Health Information Exchange / Alaska
Project Description
Project Details -
Completed
Contract Number
290-05-0015-RTI-034
Funding Mechanism(s)
Health Information Security and Privacy Colla…
-
digital.ahrq.gov/ahrq-funded-projects/privacy-and-security-solutions-interoperable-hie-wv
January 01, 2023 - Privacy and Security Solutions for Interoperable Health Information Exchange / West Virginia
Project Description
Project Details -
Completed
Contract Number
290-05-0015-RTI-010
Funding Mechanism(s)
Health Information Security and Privac…
-
cds.ahrq.gov/contact-us
Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
hcup-us.ahrq.gov/reports/PDMPsAndOpioidHospitalizations.pdf
October 03, 2017 - laws, state demonstration and community-based programs that
address opioid use, or the triplicate form … requirement for opioid prescribing (a three-copy
prescription form with copies going to the physician
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis-june-2019
June 11, 2019 - Pharmacokinetic data suggest that maximum levels of tenofovir diphosphate (the active form of tenofovir … Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/genital-herpes-screening-november-2016
December 20, 2016 - Data Synthesis and Analysis
Findings for each question were summarized in tabular and narrative form … Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/skin-cancer-screening-2001
April 01, 2001 - Nonmelanoma Skin Cancer
Basal cell carcinoma and squamous cell carcinoma are the most common forms … Recent incidence trends imply a nonmetastasizing form of invasive melanoma.